Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that it shipped the first 10,000 LuViva® Advanced Cervical Scan single-patient-use Cervical Guide disposables for...
Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today it believes it has reached a general agreement with the U.S. Food and Drug Administration (FDA) on a plan for...
Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that it will be presenting at the LD Micro “Main Event” Investor Conference to be held December 1-3, 2015 at the...
Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that it reported third quarter financial results for the period ended September 30, 2015. Guided Therapeutics...
Professor Issac Adewole, M.D., the newly appointed Minister of Health for Nigeria, is an early proponent of the benefits of using the LuViva® Advanced Cervical Scan from Guided Therapeutics, Inc. (OTCQB: GTHP) and conducted the first clinical trial of the product in...
Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that it will report its 2015 third quarter financial results following the market close on Thursday, November 12,...
